KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Divestments (2017 - 2025)

Bausch Health Companies' Divestments history spans 9 years, with the latest figure at $7.0 million for Q3 2025.

  • For Q3 2025, Divestments rose 40.0% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $7.0 million, changed 0.0%, while the annual FY2025 figure was $7.0 million, 0.0% changed from the prior year.
  • Divestments for Q3 2025 was $7.0 million at Bausch Health Companies, up from $5.0 million in the prior quarter.
  • Across five years, Divestments topped out at $740.0 million in Q1 2021 and bottomed at $1.0 million in Q2 2023.
  • The 5-year median for Divestments is $5.0 million (2022), against an average of $156.4 million.
  • The largest annual shift saw Divestments soared 3423.81% in 2021 before it changed 0.0% in 2024.
  • A 5-year view of Divestments shows it stood at $644.0 million in 2021, then plummeted by 99.22% to $5.0 million in 2022, then decreased by 20.0% to $4.0 million in 2023, then increased by 25.0% to $5.0 million in 2024, then soared by 40.0% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Divestments are $7.0 million (Q3 2025), $5.0 million (Q3 2024), and $1.0 million (Q2 2024).